Control of CD8+ T cell migration and activation by Flightless-1
Control of CD8+ T cell migration and activation by Flightless-1
批准号:
10366045
负责人:
Daniel J Campbell
金额:
$21.76万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-05 至 2023-02-28
关键词:
ActinsAddressAntigen-Presenting CellsBundlingCCL21 geneCD28 geneCD8-Positive T-LymphocytesCDC42 geneCellsCellular ImmunityCellular StructuresComplexCytoplasmic GranulesCytoskeletonDataDevelopmentDistalDrosophila genusEmbryoEquilibriumExocytosisF-ActinFamilyFamily memberG ActinGelsolinGenesGrowthHomeostasisImmunologic SurveillanceImpairmentIntegrinsKnockout MiceLeucine-Rich RepeatLinkLymphoid TissueMature T-LymphocyteMediatingMicrofilamentsMolecularMonomeric GTP-Binding ProteinsMusMuscleMyofibrilsN-terminalPeripheralPhysiologicalPolymersPositioning AttributeProcessProtein FamilyProteinsRoleSignal PathwaySignal TransductionSiteStructureT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTestingTissuesWASP proteinactin capping proteinbasecell motilitychemokineconditional knockoutcytotoxicimmunological synapseimmunological synapse formationin vivoinnovationinsightmembermigrationmouse modelnovelpolarized cellprotein protein interactionresponserho
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Adaptive immune surveillance depends on the ability of T cells to successfully migrate through secondary
lymphoid tissues and form immune-synapses with antigen-presenting cells. Precise and dynamic organization
of the actin cytoskeleton is essential for both of these processes. In migrating T cells rapid reorganization of the
actin cytoskeleton is essential for cell polarization and chemotactic responses required for tissue entry and
proper micro-environmental positioning. During T cell activation, changes in the actin cytoskeleton control proper
formation of the immunological synapse, a highly organized cellular structure that allows T cells to properly
integrate signals from the T cell receptor with those from co-stimulatory molecules such as CD28 and integrins
such as LFA-1 (αLβ2). Flightless-1 (Flii) was initially identified in Drosophila as an actin modifying protein that
controls actin myofibril structure in the muscles that control flight. Flii contains an N-terminal leucine-rich repeat
(LRR) domain that facilitates protein-protein interaction and has been implicated in control of Ras activation of
Erk/Mapk signaling, Rac1 activation and PI3K signaling. The Flii C-terminus encodes 6 gelsolin-related domains
that can interact with actin and regulate actin filament assembly/disassembly. Based on its unique domain
structure, we hypothesize that Flii acts as a key regulator of CD8+ T cell homeostasis and function by linking
changes in the actin cytoskeleton during cell migration and activation with spatial control of various signaling
cascades. We will use state-of-the-art cellular and molecular techniques to study Flii function in physiologically
relevant and innovative mouse models. Completion of these studies will provide important new insights into a
novel and completely uncharacterized signaling hub that regulates CD8+ T cell-mediated immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Il-2-mediated immune tolerance
-
批准号:10608299
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2023
-
负责人:Daniel J Campbell
-
依托单位:
Reprogramming of tissue structural cells by cutaneous CD4+ T cells
-
批准号:10608777
-
项目类别:
-
资助金额:$64.57万
-
财政年份:2023
-
负责人:Daniel J Campbell
-
依托单位:
Control of CD8+ T cell migration and activation by Flightless-1
-
批准号:10155177
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2021
-
负责人:Daniel J Campbell
-
依托单位:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
-
批准号:10358624
-
项目类别:
-
资助金额:$75.42万
-
财政年份:2021
-
负责人:Daniel J Campbell
-
依托单位:
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
-
批准号:10553203
-
项目类别:
-
资助金额:$75.42万
-
财政年份:2021
-
负责人:Daniel J Campbell
-
依托单位:
Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells
-
批准号:9384627
-
项目类别:
-
资助金额:$50.32万
-
财政年份:2017
-
负责人:Daniel J Campbell
-
依托单位:
Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells
-
批准号:9926223
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2017
-
负责人:Daniel J Campbell
-
依托单位:
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
-
批准号:10307124
-
项目类别:
-
资助金额:$67.93万
-
财政年份:2017
-
负责人:Daniel J Campbell
-
依托单位:
Targeting the IL-2/regulatory T cell axis for autoimmune disease prevention in realistic animal models
-
批准号:10062808
-
项目类别:
-
资助金额:$67.93万
-
财政年份:2017
-
负责人:Daniel J Campbell
-
依托单位:
Control of CD8+ T cell activation and differentiation by the signaling adaptor BCAP
-
批准号:9177685
-
项目类别:
-
资助金额:$53.13万
-
财政年份:2016
-
负责人:Daniel J Campbell
-
依托单位:
Functional specialization of Foxp3+ regulatory T cells
-
批准号:7988194
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Control of regulatory T cell homeostasis and function by the TH1
-
批准号:8005429
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Functional specialization of Foxp3+ regulatory T cells
-
批准号:8468099
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Functional specialization of Foxp3+ regulatory T cells
-
批准号:8662166
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Functional specialization of Foxp3+ regulatory T cells
-
批准号:8075578
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Functional specialization of Foxp3+ regulatory T cells
-
批准号:8277287
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2010
-
负责人:Daniel J Campbell
-
依托单位:
Regulation of TSLP-Mediated Skin Inflammation
-
批准号:8460069
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2009
-
负责人:Daniel J Campbell
-
依托单位:
Regulation of TSLP-Mediated Skin Inflammation
-
批准号:7655225
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2009
-
负责人:Daniel J Campbell
-
依托单位:
Homing and Homeostasis of Regulatory T cells
-
批准号:7921853
-
项目类别:
-
资助金额:$42.26万
-
财政年份:2009
-
负责人:Daniel J Campbell
-
依托单位:
Regulation of TSLP-Mediated Skin Inflammation
-
批准号:8259701
-
项目类别:
-
资助金额:$39.13万
-
财政年份:2009
-
负责人:Daniel J Campbell
-
依托单位:
海外基金